Drug discrimination under a concurrent schedule
Related Experiment Video
Updated: Nov 5, 2026

An Operant Intra-/Extra-dimensional Set-shift Task for Mice
Published on: January 22, 2016
1University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Abstract:
Three pigeons were trained to discriminate a 5.0 mg/kg dose of pentobarbital from saline under a two-key concurrent schedule with responding on the key associated with the presession injection, under both stimulus conditions, producing four times as many reinforcers as responding on the other key. This concurrent schedule resulted in approximately 70% responding to the higher reinforcement key under the pentobarbital stimulus and approximately 30% responding to that key under the saline stimulus. During testing, then, the pigeons were able to dose-dependently emit higher (>70%) or lower (<30%) values than were established under the control conditions. Dose-response curves were determined for pentobarbital (twice), methamphetamine, phencyclidine, chlordiazepoxide, and the combination of pentobarbital and the barbiturate antagonist bemegride. The results obtained with pentobarbital and chlordiazepoxide showed that, as the dose increased, pentobarbital-appropriate responding also increased. Methamphetamine produced relatively flat dose--response curves, whereas phencyclidine administration produced inconsistent effects on responding. The combination of the training dose of pentobarbital with increasing doses of bemegride produced a decrease in pentobarbital-appropriate responding. The results also showed that the dose-response curves for pentobarbital and chlordiazepoxide, instead of being all or none, were graded functions of the drug dose.
Related Concept Videos
Bioequivalence of Drugs: Drugs with Multiple Indications
Stereotypes, Prejudice, and Discrimination
Reinforcement Schedules
Once a behavior is learned,...
Drug Classes and Categories
Modified-Release Drug Delivery Systems: Rate-Programmed I
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

